HEADER VIRAL PROTEIN 10-JUL-23 8K19 TITLE NEUTRALIZATION ANTIBODY ZCP3B4 BOUND WITH SARS-COV-2 OMICRON BA.5 RBD COMPND MOL_ID: 1; COMPND 2 MOLECULE: ZCP3B4 HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ZCP3B4 LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: E; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 13 2; SOURCE 14 ORGANISM_TAXID: 2697049; SOURCE 15 GENE: S, 2; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR B.TANG,S.DANG REVDAT 2 30-OCT-24 8K19 1 REMARK REVDAT 1 09-OCT-24 8K19 0 JRNL AUTH B.TANG,S.DANG JRNL TITL NEUTRALIZATION ANTIBODY ZCP3B4 BOUND WITH SARS-COV-2 OMICRON JRNL TITL 2 BA.5 RBD JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.880 REMARK 3 NUMBER OF PARTICLES : 215557 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8K19 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ. REMARK 100 THE DEPOSITION ID IS D_1300039263. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : NEUTRALIZATION ANTIBODY ZCP3B4 REMARK 245 BOUND WITH SARS-COV-2 OMICRON REMARK 245 BA.5 RBD REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : SPOT SCAN REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU E 518 REMARK 465 HIS E 519 REMARK 465 ALA E 520 REMARK 465 PRO E 521 REMARK 465 ALA E 522 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD2 LEU E 455 OE1 GLN E 493 1.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 50 CB - CG - OD2 ANGL. DEV. = -7.5 DEGREES REMARK 500 ARG A 97 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 97 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 ARG B 61 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 TYR E 501 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 26 -18.35 58.10 REMARK 500 ASN B 30 -100.99 57.84 REMARK 500 LYS B 31 -0.97 -154.63 REMARK 500 LEU B 47 -55.31 -121.45 REMARK 500 SER B 52 10.47 -177.41 REMARK 500 ILE B 83 104.77 -57.49 REMARK 500 CYS B 88 78.46 -114.64 REMARK 500 ASP E 389 31.07 -84.23 REMARK 500 ASP E 428 26.68 -65.25 REMARK 500 SER E 459 166.41 60.41 REMARK 500 ASN E 487 11.22 56.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 GLU A 46 0.08 SIDE CHAIN REMARK 500 TYR A 59 0.07 SIDE CHAIN REMARK 500 TYR A 93 0.07 SIDE CHAIN REMARK 500 ARG B 61 0.08 SIDE CHAIN REMARK 500 HIS B 93 0.11 SIDE CHAIN REMARK 500 GLU B 105 0.12 SIDE CHAIN REMARK 500 ASN E 334 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 CYS A 22 10.50 REMARK 500 GLU A 26 -14.53 REMARK 500 TYR E 453 10.55 REMARK 500 GLN E 493 11.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-36789 RELATED DB: EMDB REMARK 900 NEUTRALIZATION ANTIBODY ZCP3B4 BOUND WITH SARS-COV-2 OMICRON BA.5 REMARK 900 RBD DBREF 8K19 A 1 119 PDB 8K19 8K19 1 119 DBREF 8K19 B 1 107 PDB 8K19 8K19 1 107 DBREF 8K19 E 334 526 UNP P0DTC2 SPIKE_SARS2 334 526 SEQADV 8K19 ASP E 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 8K19 LYS E 346 UNP P0DTC2 ARG 346 VARIANT SEQADV 8K19 PRO E 348 UNP P0DTC2 ALA 348 CONFLICT SEQADV 8K19 GLU E 354 UNP P0DTC2 ASN 354 CONFLICT SEQADV 8K19 LYS E 357 UNP P0DTC2 ARG 357 CONFLICT SEQADV 8K19 PHE E 371 UNP P0DTC2 SER 371 VARIANT SEQADV 8K19 THR E 372 UNP P0DTC2 ALA 372 CONFLICT SEQADV 8K19 PRO E 373 UNP P0DTC2 SER 373 VARIANT SEQADV 8K19 ALA E 376 UNP P0DTC2 THR 376 VARIANT SEQADV 8K19 ALA E 384 UNP P0DTC2 PRO 384 CONFLICT SEQADV 8K19 SER E 393 UNP P0DTC2 THR 393 CONFLICT SEQADV 8K19 VAL E 402 UNP P0DTC2 ILE 402 CONFLICT SEQADV 8K19 LYS E 403 UNP P0DTC2 ARG 403 CONFLICT SEQADV 8K19 ASN E 405 UNP P0DTC2 ASP 405 VARIANT SEQADV 8K19 ASP E 406 UNP P0DTC2 GLU 406 CONFLICT SEQADV 8K19 SER E 408 UNP P0DTC2 ARG 408 VARIANT SEQADV 8K19 ASN E 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 8K19 MET E 430 UNP P0DTC2 THR 430 CONFLICT SEQADV 8K19 LEU E 434 UNP P0DTC2 ILE 434 CONFLICT SEQADV 8K19 THR E 438 UNP P0DTC2 SER 438 CONFLICT SEQADV 8K19 ARG E 439 UNP P0DTC2 ASN 439 CONFLICT SEQADV 8K19 LYS E 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 8K19 ILE E 441 UNP P0DTC2 LEU 441 CONFLICT SEQADV 8K19 ALA E 443 UNP P0DTC2 SER 443 CONFLICT SEQADV 8K19 THR E 444 UNP P0DTC2 LYS 444 VARIANT SEQADV 8K19 SER E 445 UNP P0DTC2 VAL 445 CONFLICT SEQADV 8K19 THR E 446 UNP P0DTC2 GLY 446 CONFLICT SEQADV 8K19 ARG E 452 UNP P0DTC2 LEU 452 VARIANT SEQADV 8K19 ASN E 477 UNP P0DTC2 SER 477 VARIANT SEQADV 8K19 LYS E 478 UNP P0DTC2 THR 478 VARIANT SEQADV 8K19 ALA E 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 8K19 VAL E 486 UNP P0DTC2 PHE 486 VARIANT SEQADV 8K19 SER E 496 UNP P0DTC2 GLY 496 VARIANT SEQADV 8K19 ARG E 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 8K19 TYR E 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 8K19 HIS E 505 UNP P0DTC2 TYR 505 VARIANT SEQRES 1 A 119 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 A 119 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLU SEQRES 3 A 119 ILE ILE VAL SER SER ASN TYR MET ARG TRP VAL ARG GLN SEQRES 4 A 119 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER ASP ILE TYR SEQRES 5 A 119 PRO GLY GLY THR THR TYR TYR ALA ASP SER VAL LYS GLY SEQRES 6 A 119 ARG PHE SER ILE SER ARG ASP ASN SER LYS ASN THR MET SEQRES 7 A 119 TYR LEU GLN MET SER ASP LEU ARG ALA GLU ASP THR ALA SEQRES 8 A 119 VAL TYR TYR CYS ALA ARG PRO ILE MET GLY GLY ARG HIS SEQRES 9 A 119 GLY MET ASP VAL TRP GLY GLN GLY THR THR VAL THR VAL SEQRES 10 A 119 SER SER SEQRES 1 B 107 ASP ILE GLN MET THR GLN SER PRO ALA SER LEU SER ALA SEQRES 2 B 107 SER VAL GLY ASP ARG VAL THR ILE SER CYS GLN ALA SER SEQRES 3 B 107 GLN ASP ILE ASN LYS TYR LEU ASN TRP TYR GLN HIS LYS SEQRES 4 B 107 PRO GLY ARG ALA PRO LYS LEU LEU ILE PHE ASP ALA SER SEQRES 5 B 107 THR LEU GLU THR GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 B 107 GLY SER GLY THR HIS PHE THR LEU THR ILE SER SER LEU SEQRES 7 B 107 GLN PRO GLU ASP ILE ALA THR TYR TYR CYS LEU GLN HIS SEQRES 8 B 107 ASP HIS VAL PRO LEU THR PHE GLY GLY GLY THR LYS VAL SEQRES 9 B 107 GLU ILE LYS SEQRES 1 E 193 ASN LEU CYS PRO PHE ASP GLU VAL PHE ASN ALA THR LYS SEQRES 2 E 193 PHE PRO SER VAL TYR ALA TRP GLU ARG LYS LYS ILE SER SEQRES 3 E 193 ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN PHE THR SEQRES 4 E 193 PRO PHE SER ALA PHE LYS CYS TYR GLY VAL SER ALA THR SEQRES 5 E 193 LYS LEU ASN ASP LEU CYS PHE SER ASN VAL TYR ALA ASP SEQRES 6 E 193 SER PHE VAL VAL LYS GLY ASN ASP VAL SER GLN ILE ALA SEQRES 7 E 193 PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN TYR LYS SEQRES 8 E 193 LEU PRO ASP ASP PHE MET GLY CYS VAL LEU ALA TRP ASN SEQRES 9 E 193 THR ARG LYS ILE ASP ALA THR SER THR GLY ASN TYR ASN SEQRES 10 E 193 TYR ARG TYR ARG LEU PHE ARG LYS SER ASN LEU LYS PRO SEQRES 11 E 193 PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA GLY SEQRES 12 E 193 ASN LYS PRO CYS ASN GLY VAL ALA GLY VAL ASN CYS TYR SEQRES 13 E 193 PHE PRO LEU GLN SER TYR SER PHE ARG PRO THR TYR GLY SEQRES 14 E 193 VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SER PHE SEQRES 15 E 193 GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY HELIX 1 AA1 ILE A 28 ASN A 32 5 5 HELIX 2 AA2 ASP A 61 LYS A 64 5 4 HELIX 3 AA3 ARG A 86 THR A 90 5 5 HELIX 4 AA4 GLN B 79 ILE B 83 5 5 HELIX 5 AA5 PHE E 338 ASN E 343 1 6 HELIX 6 AA6 SER E 349 TRP E 353 5 5 HELIX 7 AA7 TYR E 365 ASN E 370 1 6 HELIX 8 AA8 ASN E 405 ILE E 410 5 6 HELIX 9 AA9 GLY E 416 ASN E 422 1 7 HELIX 10 AB1 GLY E 502 HIS E 505 5 4 SHEET 1 AA1 4 LEU A 4 SER A 7 0 SHEET 2 AA1 4 LEU A 20 ALA A 24 -1 O ALA A 23 N VAL A 5 SHEET 3 AA1 4 THR A 77 MET A 82 -1 O MET A 78 N CYS A 22 SHEET 4 AA1 4 PHE A 67 ASP A 72 -1 N ASP A 72 O THR A 77 SHEET 1 AA2 5 THR A 57 TYR A 59 0 SHEET 2 AA2 5 LEU A 45 ILE A 51 -1 N ASP A 50 O TYR A 58 SHEET 3 AA2 5 MET A 34 GLN A 39 -1 N ARG A 38 O GLU A 46 SHEET 4 AA2 5 ALA A 91 PRO A 98 -1 O TYR A 94 N VAL A 37 SHEET 5 AA2 5 MET A 106 TRP A 109 -1 O VAL A 108 N ARG A 97 SHEET 1 AA3 5 THR A 57 TYR A 59 0 SHEET 2 AA3 5 LEU A 45 ILE A 51 -1 N ASP A 50 O TYR A 58 SHEET 3 AA3 5 MET A 34 GLN A 39 -1 N ARG A 38 O GLU A 46 SHEET 4 AA3 5 ALA A 91 PRO A 98 -1 O TYR A 94 N VAL A 37 SHEET 5 AA3 5 THR A 113 VAL A 115 -1 O THR A 113 N TYR A 93 SHEET 1 AA4 4 MET B 4 SER B 7 0 SHEET 2 AA4 4 VAL B 19 ALA B 25 -1 O SER B 22 N SER B 7 SHEET 3 AA4 4 HIS B 70 ILE B 75 -1 O LEU B 73 N ILE B 21 SHEET 4 AA4 4 PHE B 62 SER B 67 -1 N SER B 63 O THR B 74 SHEET 1 AA5 6 SER B 10 ALA B 13 0 SHEET 2 AA5 6 THR B 102 ILE B 106 1 O LYS B 103 N LEU B 11 SHEET 3 AA5 6 ALA B 84 LEU B 89 -1 N ALA B 84 O VAL B 104 SHEET 4 AA5 6 ASN B 34 HIS B 38 -1 N HIS B 38 O THR B 85 SHEET 5 AA5 6 LYS B 45 PHE B 49 -1 O LYS B 45 N GLN B 37 SHEET 6 AA5 6 THR B 53 LEU B 54 -1 O THR B 53 N PHE B 49 SHEET 1 AA6 5 GLU E 354 ILE E 358 0 SHEET 2 AA6 5 PHE E 392 LYS E 403 -1 O ALA E 397 N LYS E 356 SHEET 3 AA6 5 PRO E 507 LEU E 517 -1 O SER E 514 N TYR E 396 SHEET 4 AA6 5 GLY E 431 ASN E 437 -1 N TRP E 436 O ARG E 509 SHEET 5 AA6 5 ALA E 376 TYR E 380 -1 N ALA E 376 O ALA E 435 SHEET 1 AA7 3 GLU E 354 ILE E 358 0 SHEET 2 AA7 3 PHE E 392 LYS E 403 -1 O ALA E 397 N LYS E 356 SHEET 3 AA7 3 VAL E 524 VAL E 524 -1 O VAL E 524 N PHE E 392 SHEET 1 AA8 2 ARG E 452 ARG E 454 0 SHEET 2 AA8 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AA9 2 TYR E 473 GLN E 474 0 SHEET 2 AA9 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SSBOND 1 CYS A 22 CYS A 95 1555 1555 2.03 SSBOND 2 CYS B 23 CYS B 88 1555 1555 2.04 SSBOND 3 CYS E 336 CYS E 361 1555 1555 2.03 SSBOND 4 CYS E 379 CYS E 432 1555 1555 2.05 SSBOND 5 CYS E 391 CYS E 525 1555 1555 2.05 SSBOND 6 CYS E 480 CYS E 488 1555 1555 2.03 CISPEP 1 SER B 7 PRO B 8 0 -18.45 CISPEP 2 VAL B 94 PRO B 95 0 -3.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000